The Indiana Clinical and Translational Sciences Institute (CTSI) Research Core Technology Seminar Series is resuming for the fall. The next event will be on Friday, September 10 from 12:00 pm – 1:00pm.
Seminar title: Preclinical Modeling & Therapeutics Core – Updates & Opportunities
Speakers: Karen E. Pollok, PhD, Director; Paul R. Territo, PhD, Scientific Director, IVIS SpectrumCT Technology; Tony L. Sinn, BS, Manager, In Vivo Therapeutics; Emily C. Sims, BS, Manager, Cellular Response Technologies
Speaker institution: Indiana University School of Medicine
Hosted by: Indiana University School of Medicine Preclinical Modeling and Therapeutics Core, Indiana University Simon Comprehensive Cancer Center
The Preclinical Modeling and Therapeutics Core (PMTC) is a recently consolidated core consisting of the Angio BioCore and the In Vivo Therapeutics Core. The PMTC facilitates the development and testing of pharmacological and cellular therapies for cancer. It provides advanced resources essential for the preclinical validation of novel drug targets and biomarkers of cancer. In this seminar, the team will provide a brief overview of services offered. This will be followed by focused discussions on the Incucyte S3 Live-Cell Analysis (Sartorius) for in vitro cellular response studies and the IVIS SpectrumCT In Vivo Imaging System (PerkinElmer) for in vivo tracking of tumor response.
The purpose of this seminar series is to inform investigators about how existing or new technologies offered by the core facilities at Indiana University, Purdue University and the University of Notre Dame could be useful in advancing their research.
